Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02428 |
| Species: | Mus musculus |
| Position : | chr8:124371000-124371500 |
| Year: | 2019 |
| Title: | An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 31406377 |
| MONDO: | |
| Tissue: | Bone Marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | Pre-cDC1 |
| CVCL ID: | |
| Cell Type: | conventional dendritic cell |
| Cell Ontology ID: | CL:0000451 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | ATAC-seq, ChIP-seq, RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | Irf8 |
| TF name : | Batf3; Irf8 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02427 | chr8:124371000-124371500 | Spleen | conventional dendritic cell | -- |